Monitoring BCG immunotherapy for high risk urothelial cancer of the urinary bladder - a novel biomarker

被引：0
|
作者：
Ardelt, P. U. [1 ]
Kneitz, B. [1 ]
Adam, P. [2 ]
Reiss, C. [3 ]
Kocot, A. [1 ]
Fensterle, J. [4 ]
Pasqualini, R. [5 ]
Arap, W. [5 ]
Gerharz, E. W. [1 ]
Riedmiller, H. [1 ]
机构：
[1] Bavarian Julius Maximilians Univ, Dept Urol & Pediat Urol, Sch Med, Wurzburg, Germany
[2] Bavarian Julius Maximilians Univ, Inst Pathol, Sch Med, Wurzburg, Germany
[3] Avarian Julius Maximilians Univ, Sch Med, Wurzburg, Germany
[4] Bavarian Julius Maximilians Univ, Sch Med, Inst Med Radiol & Cell Res, Wurzburg, Germany
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(09)72140-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [31] BCG VACCINE IN URINARY-BLADDER CANCER
    BROSMAN, SA
    WESTERN JOURNAL OF MEDICINE, 1991, 155 (06): : 633 - 633
  • [32] Relevance of urinary interferon-gamma in the prognosis of superficial bladder cancer treated with BCG immunotherapy
    Zoumpos, I.
    Touloupidis, S.
    Giakoumelos, A.
    Galaktidou, T.
    Kortsaris, A.
    Simopoulos, K.
    Katsikas, V.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 146 - 146
  • [33] Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond
    Wu, Yin
    Enting, Deborah
    Rudman, Sarah
    Chowdhury, Simon
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 509 - 523
  • [34] Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
    Krajewski, Wojciech
    Karabon, Lidia
    Partyka, Anna
    Tomkiewicz, Anna
    Poletajew, Slawomir
    Tukiendorf, Andrzej
    Kolodziej, Anna
    Zdrojowy, Romuald
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 45 (01) : 37 - 47
  • [35] Anoikis-related gene signature as novel prognostic biomarker to predict immunotherapy with bladder urothelial carcinoma
    Zhang, Hongtuan
    Liu, Dongze
    Xu, Shengxian
    Qin, Zheng
    Yi, Bocun
    Yang, Kuo
    Liu, Ranlu
    Xu, Yong
    ONCOLOGIE, 2023, 25 (03) : 291 - 308
  • [36] ARTHRITIS AFTER BCG IMMUNOTHERAPY FOR BLADDER-CANCER
    ORTI, A
    MARTINEZ, C
    CHAZARRA, C
    PINAS, I
    MEDICINA CLINICA, 1993, 100 (04): : 158 - 159
  • [37] Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer
    Mark P. Simons
    William M. Nauseef
    Thomas S. Griffith
    Immunologic Research, 2007, 39 : 79 - 93
  • [38] BCG infection following intravesicular immunotherapy for bladder cancer
    Levi, L.
    Groh, M.
    De Castro, N.
    Bergeron, A.
    Schlemmer, F.
    REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (04) : 416 - 429
  • [39] Unusual Complication of Intravesical BCG immunotherapy for Bladder Cancer
    Combs-Schildt, A.
    Gordon, R.
    Nau, K. C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S163 - S164
  • [40] BCG immunotherapy for bladder cancer—the effects of substrain differences
    Christine Gan
    Hugh Mostafid
    Muhammad Shamim Khan
    David J. M. Lewis
    Nature Reviews Urology, 2013, 10 : 580 - 588
12345